Passion for Your Process, Product, and Patients
August 1, 2013
2 Min Read
Contract manufacturing of biologics is more than having superior technology — it’s having experienced people who are passionate, responsive, and committed to developing and manufacturing your biotherapeutics to improve patient care. As a fully integrated contract development and manufacturing organization (CDMO), Therapure Biomanufacturing has the scientific and technical expertise to successfully deliver at every stage of product development (preclinical, clinical, and commercial). Our 130,000-ft2 (12,000-m2) CGMP manufacturing facility meets FDA, EMA, and HPFB regulatory standards and includes flexible clinical and commercial production suites.
Therapure appreciates the complexity of the development process. Our range of services is supported by a deep scientific understanding of process and analytical development. Our development services include
Cell Line: generation of well-characterized, stable mammalian cell lines
Upstream: development of scalable cell culture processes
Downstream: development of reproducible, scalable, and cost-effective processes for purification of proteins from a number of biological sources including plasma, transgenic sources, and mammalian cell culture
Analytical Methods: bioanalytical assay development and characterization throughout the product development stages.
We recognize that a strategic partnership with you is required to achieve complex current good manufacturing practice (CGMP) manufacturing solutions. We meet your clinical and commercial CGMP manufacturing needs through superior technology and scientific expertise. Our CGMP manufacturing services include
Upstream Processing: mammalian cell culture capacities from 50 L to 2,500 L
Downstream Processing: purification techniques including chromatography, fractional precipitation, pasteurization, and virus removal/inactivation
QC Analytical Testing: CGMP analytical laboratories that provide comprehensive analytical testing in support of development and manufacturing.
A key aspect of biotherapeutic manufacturing is the delivery of a sterile product to the patient. Therapure’s state-of-the-art facility supports aseptic fill of your biologic products from preclinical stages through clinical trials to commercial manufacturing. Our aseptic fill/finish services include
Preformed IV bags
Therapure uses a broad range of technologies to support the development and manufacture of your biotherapeutics, which minimize logistics and reduce risk. Some of our support services include
Regulatory (preparation of CMC-supporting documentation)
Warehousing and material handling
We invite you to feel the difference at Therapure Biomanufacturing, where the client experience is our passion and patient care is our commitment.
About the Author
Dina Iezzi is director of marketing and special projects at Therapure Biopharma, Inc., 2585 Meadowpine Boulevard, Mississauga, ON, Canada L5N 8H9; 1-905-286-6270; [email protected]; www.therapurebio.com.
Ins & Outs: Gonzalez but not forgotten at AbbVieFeb 29, 2024|2 Min Read
Miltenyi: MoU ‘paves way’ for India’s CGT ambitionsFeb 29, 2024|2 Min Read
Experic expands into Europe with Ireland facilityFeb 29, 2024|2 Min Read
Peas in a pod: BioCina and NovaCina ink fill/finish dealFeb 28, 2024|1 Min Read
Mar 11 - Mar 14, 2024
Mar 11 - Mar 14, 2024
Accelerate speed to market for your next generation mAbs, vaccines, cell therapy, and gene therapy products. At the BioProcess International US West event in San Diego, CA, in March 2024 you can access today's innovative strategies and technologies designed to improve process efficiencies and maintain product quality across all phases of bioprocessing.Agenda